Q2 FY27 dematerialisation compliance certificate filed with BSE

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.3%Reaction day

₹22.59

prior close

₹22.81

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.8%-1.1% vs market

Commodity Chemicals peers, median of 59sector+0.6%-0.9% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 0.9 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.3+0.8-1.1+0.6-0.9

Next day

-2.1+1.0-3.2+0.7-2.8

-2.4+1.7-4.1+1.6-4.0

-5.6+0.1-5.6+0.6-6.2

-4.2+0.8-5.0-0.0-4.2

-5.6-0.9-4.7-1.0-4.5

-1.7-4.5+2.8-4.8+3.1

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 59Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Emmessar Biotech submitted to BSE a Regulation 74(5) certificate from its Registrar MUFG Intime India, confirming that share certificates received for dematerialisation during the quarter ended 30 September 2026 were processed and depositories recorded as the registered owners within SEBI prescribed timelines. This is a routine quarterly compliance filing with no operational or financial data disclosed.

Likely market impact

Routine SEBI compliance submission. No effect on business, financials, or shareholding. No price-moving event.